NEWS
Medical monoliths can be smashed after Brexit
A new report written by Mark Lutter for the Adam Smith Institute reveals that Brexit provides the opportunity for the UK to become a world innovator in healthcare technology.
New report reveals opportunity for UK to be a leading medical innovator after Brexit
Britain can become a world innovator in healthcare technology following Brexit, according to a new report from the Adam Smith Institute released this morning (you can read the report in full here).
The report argues that Britain should streamline the approvals process for new medicines and health technologies, as well as allowing the use in Britain of medical products already approved by regulators in other countries with safe track records of medical regulation.
Brexit is an opportunity for Britain to overhaul and streamline its regulatory regime, giving it a unique chance to encourage more medical innovation, says the paper. Once dominated solely by multi-billion dollar companies, medical developments are increasingly coming from small start ups, which are often held back by slow and risk-averse regulators.
The UK’s Medicines & Healthcare products Regulatory Agency (MHRA) is in desperate need of reform as it struggles to adapt to new technological advances, warns the paper. Mark Lutter, the report’s author, suggests two strategies to boost the Britain’s regulatory regime. First, recognise decisions from the world’s best drug and medical device regulatory practices. Second, lower the cost of innovation here in Britain.
Under MHRA rules many new technological innovations, such as phone apps that magnify text for the short sighted, are currently counted as medical devices and subject to close oversight which deprives patients easy access to tools which would be able to improve their health or even save their lives.
As well as relaxing regulation at home, the UK should also look to use regulatory decisions made by partners in the EU and beyond. Drugs and medical devices approved by sensible regulators overseas would give Brits access to an increased number of safe and effective drugs, while at the same time cutting costs.
The world of medical innovation is rapidly changing and Brexit gives the UK the opportunity to become a leader in it. The UK can create a regulatory system that can attract the most innovative companies, says the report.
The MHRA should focus on becoming a partner to innovation, not a hindrance.Delaying lifesaving technology costs lives, the UK must seize this opportunity for regulatory reform for the health of its citizens.
Sam Bowman, Executive Director at the Adam Smith Institute, said:
“Britain has a chance to make itself a global hub for medical regulation after Brexit forces us to rethink the old ways of doing things. But we need to balance that innovation against the need for safety. This report’s solution to that need is ingenious: continue to require regulatory approval, but outsource some of that to the regulators of Japan, Germany, Canada and other safe, developed countries that also trial and approve medical products. Let’s hotwire the approvals process and unleash a new era of research and development in the field of making people live longer, happier lives. ”
Mark Lutter, author of the report and Lead Economist at NeWAY Capital, said
“The world is on the cusp of major innovations in personalized medicine, gene therapy, medical devices, and 3d printed organs. Unfortunately, regulatory agencies have slowed innovation. The MHRA, for example, classifies apps which magnify text for the visually impaired as medical devices. With Brexit, the time is right for regulatory change, to create the environment to cultivate the next generation of medical innovation.”
If you would like further information please do contact Matt Kilcoyne, Head of Communications, via email at matt@adamsmith.org | or via phone on 07584 778207.
The Adam Smith Institute is a free market, neoliberal think tank based in London. It advocates classically liberal public policies to create a richer, freer world.
Make sure you read the report today!
Media contact:
emily@adamsmith.org
Media phone: 07584778207
Archive
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- January 2021
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- September 2013
- August 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- April 2008
- March 2008
- February 2008
- November 2007
- October 2007
- September 2007
- May 2007
- April 2007